Open AccessRelapse and Treatment Adherence in Patients with Schizophrenia Switching from Paliperidone Palmitate Once-Monthly to Three-Monthly Formulation: A Retrospective Health Claims Database Analysis
Author(s) -
Gang Li,
Alexander Keenan,
Mehmet Daşkiran,
Maju Mathews,
Isaac Nuamah,
Camille Orman,
Kruti Joshi,
Arun Singh,
A. Godet,
Katalin Pungor,
Srihari Gopal
Publication year - 2021
Publication title -
patient preference and adherence
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.885
H-Index - 48
ISSN - 1177-889X
DOI - 10.2147/ppa.s322880
Subject(s) - medicine , paliperidone palmitate , hazard ratio , cohort , propensity score matching , paliperidone , retrospective cohort study , proportional hazards model , schizophrenia (object oriented programming) , antipsychotic , confidence interval , psychiatry
Relapse and treatment adherence to paliperidone palmitate once-monthly (PP1M) and three-monthly (PP3M) formulations in patients with schizophrenia were evaluated and compared using health claims data.